 Sukumar Vijayaraghavan
Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 12 | 2018 | 344 | 2.590 |
Why?
| | Olfactory Bulb | 6 | 2018 | 98 | 2.180 |
Why?
| | Acetylcholine | 6 | 2015 | 203 | 1.090 |
Why?
| | Calcium | 8 | 2015 | 1187 | 0.880 |
Why?
| | Synaptic Transmission | 5 | 2011 | 295 | 0.880 |
Why?
| | Neurosciences | 1 | 2024 | 25 | 0.860 |
Why?
| | Neurons | 8 | 2015 | 1619 | 0.730 |
Why?
| | Excitatory Postsynaptic Potentials | 6 | 2018 | 124 | 0.620 |
Why?
| | Action Potentials | 5 | 2015 | 499 | 0.620 |
Why?
| | Interneurons | 2 | 2018 | 124 | 0.560 |
Why?
| | gamma-Aminobutyric Acid | 2 | 2015 | 198 | 0.500 |
Why?
| | Pyramidal Cells | 3 | 2011 | 78 | 0.450 |
Why?
| | Astrocytes | 4 | 2009 | 217 | 0.450 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 601 | 0.430 |
Why?
| | Calcium Signaling | 4 | 2018 | 250 | 0.410 |
Why?
| | Synaptic Potentials | 1 | 2013 | 18 | 0.410 |
Why?
| | Olfactory Nerve | 1 | 2012 | 3 | 0.380 |
Why?
| | Receptors, Presynaptic | 2 | 2003 | 10 | 0.370 |
Why?
| | Mossy Fibers, Hippocampal | 2 | 2009 | 12 | 0.360 |
Why?
| | Cholinergic Neurons | 1 | 2011 | 17 | 0.360 |
Why?
| | Mice, Transgenic | 3 | 2017 | 2180 | 0.340 |
Why?
| | Neural Inhibition | 2 | 2015 | 177 | 0.320 |
Why?
| | Animals | 22 | 2024 | 37657 | 0.320 |
Why?
| | Neuroglia | 2 | 2009 | 173 | 0.320 |
Why?
| | CA3 Region, Hippocampal | 1 | 2009 | 7 | 0.310 |
Why?
| | Dentate Gyrus | 1 | 2009 | 39 | 0.310 |
Why?
| | Neuronal Plasticity | 2 | 2009 | 304 | 0.300 |
Why?
| | Synapses | 2 | 2015 | 428 | 0.300 |
Why?
| | Signal Transduction | 4 | 2015 | 5144 | 0.300 |
Why?
| | Receptors, Cholinergic | 2 | 2015 | 40 | 0.290 |
Why?
| | Glutamic Acid | 3 | 2009 | 256 | 0.280 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2008 | 107 | 0.270 |
Why?
| | Central Nervous System Diseases | 1 | 2008 | 73 | 0.260 |
Why?
| | Drug Design | 1 | 2008 | 168 | 0.260 |
Why?
| | Cell Communication | 2 | 2009 | 318 | 0.230 |
Why?
| | Hippocampus | 4 | 2011 | 939 | 0.230 |
Why?
| | Rats | 9 | 2009 | 5629 | 0.230 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 3 | 2011 | 98 | 0.230 |
Why?
| | Rats, Sprague-Dawley | 7 | 2017 | 2520 | 0.220 |
Why?
| | Mice | 8 | 2018 | 18048 | 0.210 |
Why?
| | Endoplasmic Reticulum | 1 | 2005 | 265 | 0.200 |
Why?
| | History, 20th Century | 1 | 2024 | 329 | 0.200 |
Why?
| | Septal Nuclei | 1 | 2002 | 24 | 0.190 |
Why?
| | Patch-Clamp Techniques | 2 | 2015 | 293 | 0.190 |
Why?
| | Psychiatry | 1 | 2024 | 188 | 0.180 |
Why?
| | Models, Neurological | 2 | 2015 | 251 | 0.180 |
Why?
| | Choline O-Acetyltransferase | 2 | 2011 | 24 | 0.180 |
Why?
| | Adenosine Triphosphate | 3 | 2009 | 492 | 0.170 |
Why?
| | Staining and Labeling | 2 | 2011 | 154 | 0.160 |
Why?
| | Presynaptic Terminals | 3 | 2009 | 94 | 0.160 |
Why?
| | Substance-Related Disorders | 1 | 2009 | 1100 | 0.160 |
Why?
| | Up-Regulation | 1 | 2002 | 859 | 0.160 |
Why?
| | Neurotransmitter Agents | 3 | 2009 | 81 | 0.150 |
Why?
| | Feedback, Physiological | 1 | 2018 | 81 | 0.140 |
Why?
| | Refractometry | 1 | 2017 | 31 | 0.130 |
Why?
| | Animals, Newborn | 3 | 2008 | 863 | 0.130 |
Why?
| | Optical Imaging | 1 | 2017 | 66 | 0.130 |
Why?
| | Supraoptic Nucleus | 2 | 2006 | 4 | 0.130 |
Why?
| | Cells, Cultured | 5 | 2005 | 4208 | 0.120 |
Why?
| | Mental Disorders | 1 | 2024 | 1120 | 0.120 |
Why?
| | Gap Junctions | 2 | 2009 | 63 | 0.120 |
Why?
| | Fluorescent Dyes | 3 | 2009 | 324 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 567 | 0.100 |
Why?
| | Receptors, Glutamate | 1 | 2013 | 26 | 0.100 |
Why?
| | Behavior, Animal | 2 | 2015 | 516 | 0.100 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 772 | 0.100 |
Why?
| | Nervous System | 2 | 2011 | 68 | 0.100 |
Why?
| | Fura-2 | 2 | 2009 | 12 | 0.100 |
Why?
| | Transgenes | 2 | 2011 | 186 | 0.090 |
Why?
| | Green Fluorescent Proteins | 2 | 2011 | 400 | 0.090 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2012 | 47 | 0.090 |
Why?
| | Nicotinic Antagonists | 1 | 2011 | 36 | 0.090 |
Why?
| | Nicotine | 2 | 2003 | 350 | 0.080 |
Why?
| | Indicators and Reagents | 1 | 2009 | 110 | 0.080 |
Why?
| | Receptors, Drug | 1 | 2009 | 13 | 0.080 |
Why?
| | Organ Culture Techniques | 1 | 2009 | 157 | 0.080 |
Why?
| | Vasomotor System | 1 | 2009 | 47 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 5887 | 0.070 |
Why?
| | Tetrodotoxin | 3 | 2006 | 41 | 0.070 |
Why?
| | Microcirculation | 1 | 2009 | 150 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 672 | 0.070 |
Why?
| | Allosteric Site | 1 | 2008 | 17 | 0.070 |
Why?
| | Learning | 1 | 2012 | 437 | 0.070 |
Why?
| | Mammals | 1 | 2009 | 287 | 0.070 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2008 | 159 | 0.070 |
Why?
| | Drosophila Proteins | 1 | 2009 | 204 | 0.070 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2008 | 377 | 0.060 |
Why?
| | Purinergic Agonists | 1 | 2006 | 3 | 0.060 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2009 | 226 | 0.060 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 237 | 0.060 |
Why?
| | Purinergic P2 Receptor Agonists | 1 | 2006 | 6 | 0.060 |
Why?
| | Cerebrovascular Circulation | 1 | 2009 | 271 | 0.060 |
Why?
| | Phenylephrine | 1 | 2006 | 75 | 0.060 |
Why?
| | Models, Chemical | 1 | 2008 | 272 | 0.060 |
Why?
| | Ligands | 1 | 2008 | 667 | 0.060 |
Why?
| | Synaptic Vesicles | 1 | 2005 | 41 | 0.060 |
Why?
| | Rod Cell Outer Segment | 1 | 2004 | 4 | 0.060 |
Why?
| | Retinaldehyde | 1 | 2004 | 4 | 0.060 |
Why?
| | NADP | 1 | 2004 | 53 | 0.060 |
Why?
| | Vitamin A | 1 | 2004 | 57 | 0.060 |
Why?
| | Suramin | 1 | 2002 | 8 | 0.050 |
Why?
| | Blood Cells | 1 | 2002 | 39 | 0.050 |
Why?
| | Electric Stimulation | 1 | 2002 | 281 | 0.050 |
Why?
| | Calcium Channels | 1 | 2002 | 156 | 0.050 |
Why?
| | Protein Binding | 1 | 2008 | 2239 | 0.040 |
Why?
| | Keratinocytes | 1 | 2002 | 252 | 0.040 |
Why?
| | Bungarotoxins | 1 | 2001 | 47 | 0.040 |
Why?
| | Axons | 1 | 2002 | 198 | 0.040 |
Why?
| | Aging | 1 | 2011 | 1892 | 0.040 |
Why?
| | Electrophysiology | 1 | 2001 | 217 | 0.040 |
Why?
| | Parasympathetic Nervous System | 1 | 2000 | 28 | 0.040 |
Why?
| | Humans | 4 | 2024 | 141187 | 0.040 |
Why?
| | Coloring Agents | 1 | 2000 | 96 | 0.040 |
Why?
| | Motor Neurons | 1 | 2002 | 233 | 0.040 |
Why?
| | Models, Biological | 1 | 2008 | 1828 | 0.040 |
Why?
| | Spinal Cord | 1 | 2002 | 373 | 0.040 |
Why?
| | Smoking | 1 | 2008 | 1601 | 0.040 |
Why?
| | Respiratory Mucosa | 1 | 2002 | 330 | 0.040 |
Why?
| | Cell Membrane | 1 | 2002 | 724 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2002 | 900 | 0.030 |
Why?
| | Thapsigargin | 2 | 2006 | 20 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 324 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2002 | 951 | 0.030 |
Why?
| | Male | 5 | 2017 | 69783 | 0.030 |
Why?
| | Kinetics | 2 | 2004 | 1652 | 0.020 |
Why?
| | Female | 3 | 2017 | 75515 | 0.020 |
Why?
| | Purinergic Antagonists | 1 | 2006 | 1 | 0.020 |
Why?
| | Purinergic P2 Receptor Antagonists | 1 | 2006 | 10 | 0.020 |
Why?
| | Receptors, Purinergic P2X | 1 | 2006 | 7 | 0.020 |
Why?
| | Pyridoxal Phosphate | 1 | 2006 | 24 | 0.020 |
Why?
| | Adenosine Diphosphate | 1 | 2006 | 82 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2006 | 167 | 0.020 |
Why?
| | Cadmium | 1 | 2006 | 68 | 0.020 |
Why?
| | Drug Synergism | 1 | 2006 | 375 | 0.010 |
Why?
| | Brain | 1 | 2017 | 2858 | 0.010 |
Why?
| | Rana pipiens | 1 | 2004 | 20 | 0.010 |
Why?
| | Fluorescence Recovery After Photobleaching | 1 | 2004 | 20 | 0.010 |
Why?
| | Photoreceptor Cells | 1 | 2004 | 17 | 0.010 |
Why?
| | Isomerism | 1 | 2004 | 56 | 0.010 |
Why?
| | Metabolic Clearance Rate | 1 | 2004 | 116 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1093 | 0.010 |
Why?
| | Lung | 1 | 2017 | 4134 | 0.010 |
Why?
| | Diagnostic Imaging | 1 | 2006 | 326 | 0.010 |
Why?
| | Species Specificity | 1 | 2004 | 583 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 417 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2006 | 854 | 0.010 |
Why?
| | Swimming | 1 | 2002 | 50 | 0.010 |
Why?
| | Embryo, Nonmammalian | 1 | 2002 | 169 | 0.010 |
Why?
| | Light | 1 | 2004 | 394 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2002 | 181 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2004 | 1086 | 0.010 |
Why?
| | Zebrafish | 1 | 2002 | 500 | 0.010 |
Why?
| | Cell Line | 1 | 2002 | 2885 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2002 | 2003 | 0.010 |
Why?
| | Biomarkers | 1 | 2002 | 4174 | 0.010 |
Why?
|
|
Vijayaraghavan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|